Moderna’s combined vaccine against covid-19 and influenza to enter final stages of testing this year | Science & Health

arrive modern Notify you that in your Combination vaccine against covid-19 and influenza This year it will pass the final phase of testing for adults aged 50 or older. mRNA-1083 is expected to receive approval from both regulatory agencies in 2025.

+ Do you want to know more about innovation? Between Epoca BUSINESS groups on WhatsApp.

Second is the network CNBCThe novel immunizer was developed in primary to mid-stage clinical trials and produced immune responses similar to or superior to the two influenza vaccines currently offered by GlaxoSmithKline. It also produced an immune response similar to its bivalent vaccine against covid-19, which has some micron BA.4 and BA.5 variants of the original strain of the coronavirus.

The combined injection study was conducted in two age groups: 50 to 64 years old and 65 to 79 years old. The company confirmed that the safety data for the autoinjection against covid-19 was similar in both cases.

Stéphane Bancel, CEO of the biotech, said in a statement: “The combined vaccine offers an important opportunity to improve the consumer and provider experience, increase compliance with public health recommendations and add additional benefits to health systems. Value.” “We are pleased to advance the combined respiratory vaccine into Phase 3 development and look forward to working with public health authorities to address the significant seasonal threat these viruses pose to people.”

In addition to this vaccine, Moderna is also developing a combination vaccine for influenza and RSV (respiratory syncytial virus), in addition to COVID-19, influenza, and RSV. Pfizer and Biological Technology It is also developing a combination product to target covid-19 and influenza – the company will begin phase testing last November and will announce it hopes to launch the product in 2024 or later.

Would you like to offer exclusive content for Época NEGÓCIOS? You can access the digital version.